The suppressed levels of infiltrated CD8+ T cells in TME were observed in rs351855-A transgenic breast cancer mouse model, as a systemic trait, which determined the immune evasion in the TME and accelerated the tumor progression [137]. This evidence concerns the gene CD8A and breast cancer.